C. Nguyen, B. Barker, and S. Hoover, Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis, Clinical Microbiology Reviews, vol.26, issue.3, pp.505-530, 2013.
DOI : 10.1128/CMR.00005-13

I. Schwartz, N. Govender, and C. Corcoran, Clinical Characteristics, Diagnosis, Management, and Outcomes of Disseminated Emmonsiosis: A Retrospective Case Series, Clinical Infectious Diseases, vol.61, issue.6, pp.1004-1016, 2015.
DOI : 10.1093/cid/civ439

K. Buchacz, B. Lau, and Y. Jing, Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000???2010, Journal of Infectious Diseases, vol.214, issue.6, pp.862-72, 2000.
DOI : 10.1093/infdis/jiw085

J. Jarvis, A. Boulle, and A. Loyse, High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out, AIDS, vol.23, issue.9, pp.1182-83, 2009.
DOI : 10.1097/QAD.0b013e32832be0fc

M. Siedner, C. Ng, I. Bassett, I. Katz, D. Bangsberg et al., Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa: a meta-analysis, Clin Infect Dis, vol.60, pp.1120-1147, 2002.

J. Beardsley, M. Wolbers, and F. Kibengo, Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis, New England Journal of Medicine, vol.374, issue.6, pp.542-54, 2016.
DOI : 10.1056/NEJMoa1509024

G. Brown, D. Denning, N. Gow, S. Levitz, M. Netea et al., Hidden Killers: Human Fungal Infections, Science Translational Medicine, vol.14, issue.2, pp.165-178, 2012.
DOI : 10.1258/0956462981922728

C. Thomas, J. Limper, and A. , Current insights into the biology and pathogenesis of Pneumocystis pneumonia, Nature Reviews Microbiology, vol.358, issue.4, pp.298-308, 2007.
DOI : 10.3201/eid0907.020753

C. Thomas, . Jr, and A. Limper, Pneumocystis Pneumonia, New England Journal of Medicine, vol.350, issue.24, pp.2487-98, 2004.
DOI : 10.1056/NEJMra032588

C. Lopez-sanchez, V. Falco, and J. Burgos, Epidemiology and Long-Term Survival in HIV-Infected Patients With Pneumocystis jirovecii Pneumonia in the HAART Era, e681. 11 Cushion MT, p.1001009, 2010.
DOI : 10.1097/MD.0000000000000681

L. Pifer, W. Hughes, S. Stagno, and D. Woods, Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children, Pediatrics, vol.61, pp.35-41, 1978.

A. Limper, K. Knox, and G. Sarosi, An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.1, pp.96-128, 2011.
DOI : 10.1164/rccm.2008-740ST

J. Chave, S. David, J. Wauters, G. Van-melle, and P. Francioli, Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients, AIDS, vol.5, issue.8, pp.927-959, 1991.
DOI : 10.1097/00002030-199108000-00002

S. Keely, R. Baughman, A. Smulian, M. Dohn, and J. Stringer, Source of pneumocystis carinii in recurrent episodes of pneumonia in AIDS patient, AIDS, vol.10, issue.8, pp.881-88, 1996.
DOI : 10.1097/00002030-199607000-00011

B. Krajicek, A. Limper, C. Thomas, and . Jr, Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia, Current Opinion in Pulmonary Medicine, vol.14, issue.3, pp.228-262, 2008.
DOI : 10.1097/MCP.0b013e3282f94abc

A. Morris, L. Kingsley, G. Groner, I. Lebedeva, C. Beard et al., Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men, AIDS, vol.18, issue.5, pp.793-98, 2004.
DOI : 10.1097/00002030-200403260-00011

J. Wilson, A. Limper, T. Grys, T. Karre, N. Wengenack et al., Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity, Diagnostic Microbiology and Infectious Disease, vol.69, issue.2, pp.145-52, 2011.
DOI : 10.1016/j.diagmicrobio.2010.10.021

A. Onishi, D. Sugiyama, and Y. Kogata, Diagnostic accuracy of serum 1,3-beta-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis, J Clin Med, vol.50, pp.7-15, 2012.

M. Lanaspa, O. Callaghan-gordo, C. Machevo, and S. , High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia, Clinical Microbiology and Infection, vol.21, issue.11, pp.1018-1027, 2015.
DOI : 10.1016/j.cmi.2015.07.011

H. Ewald, H. Raatz, R. Boscacci, H. Furrer, H. Bucher et al., Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection, Cochrane Database Syst Rev, vol.8, issue.3, p.6150, 2015.
DOI : 10.1002/14651858.CD006150

M. Bye, A. Cairns-bazarian, and J. Ewig, Markedly Reduced Mortality Associated With Corticosteroid Therapy of Pneumocystis carinii Pneumonia in Children With Acquired Immunodeficiency Syndrome, Archives of Pediatrics & Adolescent Medicine, vol.148, issue.6, pp.638-679, 1994.
DOI : 10.1001/archpedi.1994.02170060092018

H. Masur, J. Brooks, and C. Benson, Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.58, issue.9, pp.1308-1319, 2014.
DOI : 10.1093/cid/ciu094

J. Church, F. Fitzgerald, A. Walker, D. Gibb, and A. Prendergast, The expanding role of co-trimoxazole in developing countries, The Lancet Infectious Diseases, vol.15, issue.3, pp.327-366, 2015.
DOI : 10.1016/S1473-3099(14)71011-4

H. Kling and K. Norris, Coinfection, Journal of Infectious Diseases, vol.213, issue.10, pp.1586-95, 2016.
DOI : 10.1093/infdis/jiw032

J. Jarvis, T. Bicanic, and A. Loyse, Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes, Clinical Infectious Diseases, vol.58, issue.5, pp.736-781, 2014.
DOI : 10.1093/cid/cit794

J. Jarvis, A. Percival, and S. Bauman, Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis, Clinical Infectious Diseases, vol.53, issue.10, pp.1019-1042, 2011.
DOI : 10.1093/cid/cir613

J. Jarvis, S. Lawn, M. Vogt, N. Bangani, R. Wood et al., Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa, Clinical Infectious Diseases, vol.48, issue.7, pp.856-62, 2009.
DOI : 10.1086/597262

J. Perfect, W. Dismukes, and F. Dromer, Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.50, issue.3, pp.291-322, 2010.
DOI : 10.1086/649858

A. Brouwer, A. Rajanuwong, and W. Chierakul, Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial, The Lancet, vol.363, issue.9423, pp.1764-67, 2004.
DOI : 10.1016/S0140-6736(04)16301-0

J. Chau, T. Wolbers, and M. , Combination antifungal therapy for cryptococcal meningitis, N Engl J Med, vol.368, pp.1291-302, 2013.

R. Hamill, J. Sobel, and W. El-sadr, Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS???Associated Acute Cryptococcal Meningitis: A Randomized, Double???Blind Clinical Trial of Efficacy and Safety, Clinical Infectious Diseases, vol.51, issue.2, pp.225-257, 2010.
DOI : 10.1086/653606

A. Loyse, F. Dromer, J. Day, O. Lortholary, and T. Harrison, Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal, Journal of Antimicrobial Chemotherapy, vol.68, issue.11
DOI : 10.1093/jac/dkt221

J. Graybill, J. Sobel, and M. Saag, Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis, Clinical Infectious Diseases, vol.30, issue.1, pp.47-54, 2000.
DOI : 10.1086/313603

M. Rolfes, K. Hullsiek, and J. Rhein, The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis, Clinical Infectious Diseases, vol.59, issue.11, pp.1607-1621, 2014.
DOI : 10.1093/cid/ciu596

T. Bicanic, A. Brouwer, and G. Meintjes, Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures, AIDS, vol.23, pp.701-707, 2009.
DOI : 10.1097/QAD.0b013e32832605fe

K. Macsween, T. Bicanic, A. Brouwer, H. Marsh, D. Macallan et al., Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review, Journal of Infection, vol.51, issue.4, pp.221-245, 2005.
DOI : 10.1016/j.jinf.2005.02.010

R. Fessler, J. Sobel, and L. Guyot, Management of Elevated Intracranial Pressure in Patients With Cryptococcal Meningitis, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.17, issue.2, pp.137-179, 1998.
DOI : 10.1097/00042560-199802010-00006

A. Makadzange, C. Ndhlovu, and K. Takarinda, Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub???Saharan Africa, Clinical Infectious Diseases, vol.50, issue.11, pp.1532-1570, 2010.
DOI : 10.1086/652652

D. Boulware, D. Meya, and C. Muzoora, Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis, New England Journal of Medicine, vol.370, issue.26, pp.2487-98, 2014.
DOI : 10.1056/NEJMoa1312884

N. Longley, T. Harrison, and J. Jarvis, Cryptococcal immune reconstitution inflammatory syndrome, Current Opinion in Infectious Diseases, vol.26, issue.1, pp.26-34, 2013.
DOI : 10.1097/QCO.0b013e32835c21d1

T. Bicanic, G. Meintjes, and K. Rebe, Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.51, issue.2, pp.130-164, 2009.
DOI : 10.1097/QAI.0b013e3181a56f2e

D. Meya, Y. Manabe, and B. Castelnuovo, Cell Count ???100 Cells/??L Who Start HIV Therapy in Resource???Limited Settings, Clinical Infectious Diseases, vol.51, issue.4, pp.448-55, 2010.
DOI : 10.1086/655143

J. Jarvis, T. Harrison, S. Lawn, G. Meintjes, R. Wood et al., Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa, PLoS ONE, vol.99, issue.10, p.69288, 2013.
DOI : 10.1371/journal.pone.0069288.s001

S. Mfinanga, C. D. Kivuyo, and S. , Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial, The Lancet, vol.385, issue.9983, pp.2173-82, 2015.
DOI : 10.1016/S0140-6736(15)60164-7

N. Longley, J. Jarvis, and G. Meintjes, Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study, Clinical Infectious Diseases, vol.62, issue.5, pp.581-87, 2016.
DOI : 10.1093/cid/civ936

K. Smith, B. Achan, and K. Hullsiek, Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7197-204, 2015.
DOI : 10.1128/AAC.01299-15

M. Brandt, B. Gómez, and D. Warnock, Histoplasma, Blastomyces, Coccidioides, and Other Dimorphic Fungi Causing Systemic Mycoses, Manual of Clinical Microbiology, pp.1902-1920, 2011.
DOI : 10.1128/9781555816728.ch120

J. Woods, Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis, Journal of Microbiology, vol.845, issue.3, pp.265-76, 2016.
DOI : 10.1007/978-1-61779-539-8_4

A. Adenis, C. Aznar, and P. Couppie, Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps, Current Tropical Medicine Reports, vol.56, issue.6, pp.119-147, 2014.
DOI : 10.1093/cid/cis935

M. Nacher, A. Adenis, and C. Aznar, How Many Have Died from Undiagnosed Human Immunodeficiency Virus???Associated Histoplasmosis, A Treatable Disease? Time to Act, The American Journal of Tropical Medicine and Hygiene, vol.90, issue.2
DOI : 10.4269/ajtmh.13-0226
URL : https://hal.archives-ouvertes.fr/inserm-00913874

J. Wheat, Endemic mycoses in AIDS: a clinical review, Clin Microbiol Rev, vol.8, pp.146-59, 1995.

V. Peigne, F. Dromer, C. Elie, O. Lidove, and O. Lortholary, Imported Acquired Immunodeficiency Syndrome???Related Histoplasmosis in Metropolitan France: A Comparison of Pre???Highly Active Anti-Retroviral Therapy and Highly Active Anti-Retroviral Therapy Eras, The American Journal of Tropical Medicine and Hygiene, vol.85, issue.5, pp.934-975, 2011.
DOI : 10.4269/ajtmh.2011.11-0224
URL : https://hal.archives-ouvertes.fr/hal-00818505

A. Adenis, M. Nacher, and M. Hanf, HIV-Associated Histoplasmosis Early Mortality and Incidence Trends: From Neglect to Priority, PLoS Neglected Tropical Diseases, vol.90, issue.8, p.3100, 2014.
DOI : 10.1371/journal.pntd.0003100.t001
URL : https://hal.archives-ouvertes.fr/inserm-01065109

M. Hanf, A. Adenis, P. Couppie, B. Carme, and M. Nacher, HIV-associated histoplasmosis in French Guiana: recent infection or reactivation?, AIDS, vol.24, issue.11, pp.1777-78, 2010.
DOI : 10.1097/QAD.0b013e32833999c9

D. Kroetz and G. Deepe, The role of cytokines and chemokines in Histoplasma capsulatum infection, Cytokine, vol.58, issue.1, pp.112-129, 2012.
DOI : 10.1016/j.cyto.2011.07.430

R. Hajjeh, P. Pappas, and H. Henderson, Multicenter Case-Control Study of Risk Factors for Histoplasmosis in Human Immunodeficiency Virus-Infected Persons, Clinical Infectious Diseases, vol.32, issue.8, pp.1215-1235, 2001.
DOI : 10.1086/319756

M. Nacher, A. Adenis, and D. Blanchet, Risk Factors for Disseminated Histoplasmosis in a Cohort of HIV-Infected Patients in French Guiana, PLoS Neglected Tropical Diseases, vol.38, issue.1, p.2638, 2014.
DOI : 10.1371/journal.pntd.0002638.t004

B. Pauw, T. Walsh, and J. Donnelly, Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.46, issue.12, pp.1813-1834, 2008.
DOI : 10.1086/588660

L. Wheat, C. Musial, and E. Jenny-avital, Diagnosis and Management of Central Nervous System Histoplasmosis, Clinical Infectious Diseases, vol.40, issue.6, pp.844-52, 2005.
DOI : 10.1086/427880

E. Theel, J. Harring, A. Dababneh, L. Rollins, J. Bestrom et al., Reevaluation of Commercial Reagents for Detection of Histoplasma capsulatum Antigen in Urine, Journal of Clinical Microbiology, vol.53, issue.4, pp.1198-203, 2015.
DOI : 10.1128/JCM.03175-14

D. Series-63-caceres, C. Scheel, and A. Tobón, Validation in Colombia of a commercial antigen detection test for the diagnosis of progressive disseminated histoplasmosis Abstract 545. 64 Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America Clinical practice guidelines for the management of patients with histoplasmosis, 19th Congress of the International Society for Human and Animal Mycology update by the Infectious Diseases Society of America, pp.807-832, 2007.

S. Jaruratanasirikul and S. Sriwiriyajan, Pharmacokinetic study of the interaction between itraconazole and nevirapine, European Journal of Clinical Pharmacology, vol.50, issue.Suppl 2
DOI : 10.1248/bpb.23.1027

E. Huet, C. Hadji, A. Hulin, F. Botterel, S. Bretagne et al., Therapeutic monitoring is necessary for the association itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis, AIDS, vol.22, issue.14, pp.1885-86, 2008.
DOI : 10.1097/QAD.0b013e3283097d0f

A. Homei and M. Worboys, Fungal disease in Britain and the United States, mycoses and modernity 69 Neglected histoplasmosis in Latin America group. Disseminated histoplasmosis in Central and South America, the invisible elephant: the lethal blind spot of international health organizations, AIDS, vol.30, pp.167-70, 1850.

R. Murphy, L. Gounder, T. Manzini, P. Ramdial, C. Castilla et al., Challenges in the management of disseminated progressive histoplasmosis in human immunodeficiency virus-infected patients in resource-limited settings Disseminated Penicillium marneffei infection in southeast Asia, Open Forum Infect Dis Lancet, vol.2, issue.344, pp.110-123, 1994.

N. Vanittanakom, C. Cooper, . Jr, M. Fisher, and T. Sirisanthana, Penicillium marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects, Clinical Microbiology Reviews, vol.19, issue.1, pp.95-110, 2006.
DOI : 10.1128/CMR.19.1.95-110.2006

K. Supparatpinyo, S. Chiewchanvit, P. Hirunsri, C. Uthammachai, K. Nelson et al., Penicillium marneffei Infection in Patients Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, vol.14, issue.4, pp.871-74, 1992.
DOI : 10.1093/clinids/14.4.871

K. Wong, S. Lee, K. Chan, and T. Choi, Redefining AIDS: case exemplified by Penicillium marneffei infection in HIV-infected people in Hong Kong, Int J STD AIDS, vol.9, pp.555-56, 1998.

M. Larsson, L. Nguyen, and H. Wertheim, Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam, AIDS Research and Therapy, vol.9, issue.1, p.24, 2012.
DOI : 10.2165/00003088-200847100-00004

T. Le, M. Wolbers, and N. Chi, Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam, Clinical Infectious Diseases, vol.52, issue.7, pp.945-52, 2011.
DOI : 10.1093/cid/cir028

T. Nga, C. Parry, and T. Le, The decline of typhoid and the rise of non-typhoid salmonellae and fungal infections in a changing HIV landscape: bloodstream infection trends over 15 years in southern Vietnam, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.106, issue.1, pp.26-34, 2012.
DOI : 10.1016/j.trstmh.2011.10.004

S. Antinori, E. Gianelli, and C. Bonaccorso, Infection in an HIV???Positive Italian Patient and a Review of Cases Reported Outside Endemic Regions, Journal of Travel Medicine, vol.13, issue.3, pp.181-88, 2006.
DOI : 10.1111/j.1708-8305.2006.00039.x

J. Chan, T. Chan, and H. Gill, in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors, Emerging Infectious Diseases, vol.21, issue.7, pp.1101-1107, 2015.
DOI : 10.3201/eid2107.150138
URL : http://doi.org/10.3201/eid2107.150138

H. Gugnani, M. Fisher, A. Paliwal-johsi, N. Vanittanakom, I. Singh et al., Role of Cannomys badius as a Natural Animal Host of Penicillium marneffei in India, Journal of Clinical Microbiology, vol.42, issue.11, pp.5070-75, 2004.
DOI : 10.1128/JCM.42.11.5070-5075.2004

C. Cao, L. Liang, and W. Wang, Infection in Humans and Rodents, China, Emerging Infectious Diseases, vol.17, issue.2, pp.209-223, 2011.
DOI : 10.3201/eid1702.100718

S. Chariyalertsak, T. Sirisanthana, K. Supparatpinyo, J. Praparattanapan, and K. Nelson, Infection in Human Immunodeficiency Virus???Infected Patients in Northern Thailand, Clinical Infectious Diseases, vol.24, issue.6, pp.1080-86, 1997.
DOI : 10.1086/513649

T. Le, B. Jonat, K. Cuc, and N. , The exposure and geospatial risk factors for AIDS-associated penicilliosis in Vietnam, Conference on Retroviruses and Opportunistic Infections, 2015.

S. Chariyalertsak, T. Sirisanthana, K. Supparatpinyo, and K. Nelson, Seasonal Variation of Disseminated Penicillium marneffei Infections in Northern Thailand: A Clue to the Reservoir?, Journal of Infectious Diseases, vol.173, issue.6, pp.1490-93, 1996.
DOI : 10.1093/infdis/173.6.1490

Y. Hu, J. Zhang, and X. Li, Penicillium marneffei Infection: An Emerging Disease in Mainland China, Mycopathologia, vol.35, issue.6, pp.57-67, 2012.
DOI : 10.1111/j.1365-4362.1996.tb03017.x

P. Bulterys, T. Le, V. Quang, K. Nelson, and J. Lloyd-smith, Infection in Ho Chi Minh City, Vietnam, Clinical Infectious Diseases, vol.56, issue.9, pp.1273-79, 2013.
DOI : 10.1093/cid/cit058

S. Chariyalertsak, P. Vanittanakom, K. Nelson, T. Sirisanthana, and N. Vanittanakom, Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei, J Med V Med, vol.34, pp.105-115, 1996.
DOI : 10.1080/02681219680000161

X. Huang, G. He, S. Lu, Y. Liang, and L. Xi, in Guangdong, China, Microbial Biotechnology, vol.158, issue.4, pp.659-64, 2015.
DOI : 10.1023/B:MYCO.0000041842.90633.86

E. Pryce-miller, D. Aanensen, N. Vanittanakom, and M. Fisher, Environmental detection of Penicillium marneffei and growth in soil microcosms in competition with Talaromyces stipitatus, Fungal Ecology, vol.1, issue.1, pp.49-56, 2008.
DOI : 10.1016/j.funeco.2008.02.002

T. Wu, J. Chan, C. Ng, D. Tsang, M. Lee et al., Clinical presentations and outcomes of Penicillium marneffei infections: a series from, Hong Kong Med J, vol.14, pp.103-112, 1994.

V. Son, P. Khue, and M. Strobel, Penicilliosis and AIDS in Haiphong, Vietnam: Evolution and predictive factors of death, M??decine et Maladies Infectieuses, vol.44, issue.11-12, pp.495-501, 2014.
DOI : 10.1016/j.medmal.2014.09.008

L. Saikia, R. Nath, D. Hazarika, and J. Mahanta, Atypical cutaneous lesions of penicillium marneffei infection as a manifestation of the immune reconstitution inflammatory syndrome after highly active antiretroviral therapy, Indian Journal of Dermatology, Venereology and Leprology, vol.76, issue.1, pp.45-48, 2010.
DOI : 10.4103/0378-6323.58678

T. Sudjaritruk, T. Sirisanthana, and V. Sirisanthana, Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature, BMC Infectious Diseases, vol.21, issue.1, p.28, 2012.
DOI : 10.1097/01.aids.0000253374.19966.f9

S. Lu, X. Li, and R. Calderone, specific DNA for diagnosis, Medical Mycology, vol.54, issue.2, pp.162-68, 2016.
DOI : 10.1093/mmy/myv068

H. Hien, T. Thanh, and N. Thu, gene in human plasma, Mycoses, vol.21, issue.12, pp.773-80, 2016.
DOI : 10.1016/j.cmi.2014.12.014

Y. Wang, J. Cai, and Y. Wang, Immunoassays Based on Penicillium marneffei Mp1p Derived from Pichia pastoris Expression System for Diagnosis of Penicilliosis, PLoS ONE, vol.39, issue.12, p.28796, 2011.
DOI : 10.1371/journal.pone.0028796.t003

K. Prakit, J. Nosanchuk, K. Pruksaphon, N. Vanittanakom, and S. Youngchim, A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum, European Journal of Clinical Microbiology & Infectious Diseases, vol.11, issue.4
DOI : 10.1258/0956462001915372

T. Le, N. Kinh, and N. Cuc, A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis, New England Journal of Medicine, vol.376, issue.24, pp.2329-2369, 2017.
DOI : 10.1056/NEJMoa1613306

J. Kaplan, C. Benson, K. Holmes, J. Brooks, A. Pau et al., Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, MMWR Recomm Rep, vol.58, pp.1-207, 2009.
DOI : 10.1037/e537722009-001

S. Chariyalertsak, K. Supparatpinyo, T. Sirisanthana, and K. Nelson, A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand, Clinical Infectious Diseases, vol.34, issue.2, pp.277-84, 2002.
DOI : 10.1086/338154

A. Loyse, H. Thangaraj, and P. Easterbrook, Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries, The Lancet Infectious Diseases, vol.13, issue.7, pp.629-666, 2013.
DOI : 10.1016/S1473-3099(13)70078-1
URL : http://fieldresearch.msf.org/msf/bitstream/10144/295248/1/Loyse%20Cryptococcal%20meningitis%20improving%20access%20to%20essential%20antifungal%20medicines%20in%20resource-poor%20countries.pdf